Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults

Summary

The primary objective of this study is to evaluate the efficacy of Mexidol® sequential parenteral and oral administration as part of comprehensive therapy in older adults with chronic brain ischemia and vascular cognitive impairment, no dementia (VCIND).

Timeline

Start

2025-09-14

Primary completion

2025-11-05

Completion

2025-11-05

Drugs

Indications